New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound
Scientific American [Unofficial]
February 6, 2026
The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much
Discussion in the ATmosphere